These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 19688786

  • 21. Novel inhibitor of bacterial sphingomyelinase, SMY-540, developed based on three-dimensional structure analysis.
    Oda M, Imagawa H, Kato R, Yabiku K, Yoshikawa T, Takemoto T, Takahashi H, Yamamoto H, Nishizawa M, Sakurai J, Nagahama M.
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):303-10. PubMed ID: 23488740
    [Abstract] [Full Text] [Related]

  • 22. Synthesis of sphingomyelin sulfur analogue and its behavior toward sphingomyelinase.
    Hakogi T, Fujii S, Morita M, Ikeda K, Katsumura S.
    Bioorg Med Chem Lett; 2005 Apr 15; 15(8):2141-4. PubMed ID: 15808485
    [Abstract] [Full Text] [Related]

  • 23. Functional inhibitors of acid sphingomyelinase (FIASMAs).
    Kornhuber J, Tripal P, Gulbins E, Muehlbacher M.
    Handb Exp Pharmacol; 2013 Apr 15; (215):169-86. PubMed ID: 23579455
    [Abstract] [Full Text] [Related]

  • 24. Acidic extracellular pH increases calcium influx-triggered phospholipase D activity along with acidic sphingomyelinase activation to induce matrix metalloproteinase-9 expression in mouse metastatic melanoma.
    Kato Y, Ozawa S, Tsukuda M, Kubota E, Miyazaki K, St-Pierre Y, Hata R.
    FEBS J; 2007 Jun 15; 274(12):3171-83. PubMed ID: 17540003
    [Abstract] [Full Text] [Related]

  • 25. Pertussis toxin promotes macrophage survival through inhibition of acid sphingomyelinase and activation of the phosphoinositide 3-kinase/protein kinase B pathway.
    Wang SW, Parhar K, Chiu KJ, Tran A, Gangoiti P, Kong J, Gonzalez M, Salh B, Duronio V, Steinbrecher UP, Gómez-Muñoz A.
    Cell Signal; 2007 Aug 15; 19(8):1772-83. PubMed ID: 17521884
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
    Qiao L, Yacoub A, Studer E, Gupta S, Pei XY, Grant S, Hylemon PB, Dent P.
    Hepatology; 2002 Apr 15; 35(4):779-89. PubMed ID: 11915023
    [Abstract] [Full Text] [Related]

  • 27. Biochemical identification of a neutral sphingomyelinase 1 (NSM1)-like enzyme as the major NSM activity in the DT40 B-cell line: absence of a role in the apoptotic response to endoplasmic reticulum stress.
    Fensome AC, Josephs M, Katan M, Rodrigues-Lima F.
    Biochem J; 2002 Jul 01; 365(Pt 1):69-77. PubMed ID: 12071841
    [Abstract] [Full Text] [Related]

  • 28. Acid and neutral sphingomyelinases: roles and mechanisms of regulation.
    Marchesini N, Hannun YA.
    Biochem Cell Biol; 2004 Feb 01; 82(1):27-44. PubMed ID: 15052326
    [Abstract] [Full Text] [Related]

  • 29. Influence of L-carnitine on CD95 cross-lining-induced apoptosis and ceramide generation in human cell lines: correlation with its effects on purified acidic and neutral sphingomyelinases in vitro.
    Di Marzio L, Alesse E, Roncaioli P, Muzi P, Moretti S, Marcellini S, Amicosante G, De Simone C, Cifone MG.
    Proc Assoc Am Physicians; 1997 Mar 01; 109(2):154-63. PubMed ID: 9069584
    [Abstract] [Full Text] [Related]

  • 30. Molecular mechanisms of apoptosis induced by an immunomodulating peptide on human monocytes.
    Osés-Prieto JA, López-Moratalla N, Santiago E, Jaffrézou JP, López-Zabalza MJ.
    Arch Biochem Biophys; 2000 Jul 15; 379(2):353-62. PubMed ID: 10898955
    [Abstract] [Full Text] [Related]

  • 31. Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase.
    Arenz C, Gartner M, Wascholowski V, Giannis A.
    Bioorg Med Chem; 2001 Nov 15; 9(11):2901-4. PubMed ID: 11597471
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of sphingomyelinase activity helps to prevent neuron death caused by ischemic stress.
    Soeda S, Tsuji Y, Ochiai T, Mishima K, Iwasaki K, Fujiwara M, Yokomatsu T, Murano T, Shibuya S, Shimeno H.
    Neurochem Int; 2004 Oct 15; 45(5):619-26. PubMed ID: 15234103
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Neutral sphingomyelinase-inhibiting guanidines prevent herpes simplex virus-1 replication.
    Amtmann E, Zöller M, Schilling G.
    Drugs Exp Clin Res; 2000 Oct 15; 26(2):57-65. PubMed ID: 10894556
    [Abstract] [Full Text] [Related]

  • 36. Regulation of sphingomyelinases in cells of the oligodendrocyte lineage.
    Testai FD, Landek MA, Dawson G.
    J Neurosci Res; 2004 Jan 01; 75(1):66-74. PubMed ID: 14689449
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Sphingomyelin analogues as inhibitors of sphingomyelinase.
    Taguchi M, Sugimoto K, Goda K, Akama T, Yamamoto K, Suzuki T, Tomishima Y, Nishiguchi M, Arai K, Takahashi K, Kobori T.
    Bioorg Med Chem Lett; 2003 Jun 16; 13(12):1963-6. PubMed ID: 12781174
    [Abstract] [Full Text] [Related]

  • 40. Concise approach to the carbocyclic core of the naturally occurring sphingomyelinase inhibitor scyphostatin.
    Mehta G, Modugu NR.
    J Org Chem; 2013 Apr 05; 78(7):3367-73. PubMed ID: 23442124
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.